Skip to main content
XXII
NASDAQ Manufacturing

22nd Century Group's Q1 Revenue Plummets 31%, Flagship VLN® Sales Hit Zero Amid Widening Losses

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$0.842
Mkt Cap
$613.714K
52W Low
$0.79
52W High
$483
Market data snapshot near publication time

summarizeSummary

22nd Century Group reported a sharp 31.1% year-over-year revenue decline to $4.1 million in Q1 2026, alongside widening operating losses and a critical $0.0 million in net revenue from its flagship VLN® cigarettes, intensifying concerns about its financial viability.


check_boxKey Events

  • Significant Revenue Decline

    Net revenues fell 31.1% year-over-year to $4.1 million for the first quarter ended March 31, 2026.

  • Worsening Profitability

    Operating loss increased to $3.0 million and Adjusted EBITDA loss widened to $2.6 million compared to the prior year quarter.

  • Zero VLN® Cigarette Revenue

    The company's flagship VLN® product recorded $0.0 million in net revenues for the quarter, following initial stocking orders in Q4 2025, offset by customer returns and product exchanges.

  • Cash Position Amid Dilution

    Ended the quarter with $9.5 million in cash and equivalents, against a backdrop of recently authorized highly dilutive At-The-Market offerings.


auto_awesomeAnalysis

This 8-K filing reveals a deeply concerning financial performance for 22nd Century Group, with net revenues plummeting over 31% year-over-year and operating losses widening. Most critically, the company reported zero net revenue from its flagship VLN® cigarettes, a product central to its harm reduction strategy and future growth. These results significantly exacerbate the 'going concern' doubts previously disclosed in the company's 10-K and underscore the urgent need for the highly dilutive At-The-Market offerings recently authorized. Investors should view these results as a strong negative signal regarding the company's operational execution and financial stability, suggesting continued pressure on the stock.

At the time of this filing, XXII was trading at $0.84 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $613.7K. The 52-week trading range was $0.79 to $483.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed XXII - Latest Insights

XXII
May 07, 2026, 6:30 AM EDT
Filing Type: 10-Q
Importance Score:
10
XXII
May 07, 2026, 6:13 AM EDT
Source: Wiseek News
Importance Score:
8
XXII
May 07, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
9
XXII
May 01, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
9
XXII
May 01, 2026, 5:20 PM EDT
Filing Type: 8-K
Importance Score:
9
XXII
May 01, 2026, 5:15 PM EDT
Filing Type: 424B5
Importance Score:
9
XXII
Apr 29, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
XXII
Apr 10, 2026, 4:35 PM EDT
Filing Type: 424B5
Importance Score:
9
XXII
Apr 10, 2026, 4:30 PM EDT
Filing Type: 424B5
Importance Score:
9
XXII
Mar 31, 2026, 5:00 PM EDT
Filing Type: S-3
Importance Score:
9